BSE · KPL.BO
Kwality Pharmaceuticals Limited
₹3,576.90-₹104.05 (-2.83%)
Kwality Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 7.49% below the high.
Loading market information…
BSE · SHUKRAPHAR.BO · INR
Stock price, dividends
Quote as of Oct 30, 2026, 06:58 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Shukra Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 0.42% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Shukra Pharmaceuticals Limited’s forward annual dividend is ₹0.01 per share, paid annual. The forward yield is 0.01% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Shukra Pharmaceuticals Limited is a prominent company engaged in the manufacturing and global distribution of pharmaceutical products. Their comprehensive product line addresses a broad spectrum of medical conditions, encompassing anti-infective medications (such as antibiotics, macrolides, quinolones, antivirals, antifungals, antimalarials, antiprotozoals, and anti-helminthics), central nervous system drugs (including sedatives, tranquilizers, antidepressants, and anti-manic agents), gastrointestinal treatments (like anti-emetics and anti-ulcer drugs), cardiovascular remedies (beta-blockers, diuretics), pain and inflammation management (analgesics, muscle relaxants, corticosteroids), anti-tuberculosis drugs, vitamin supplements, anti-allergy medications, and therapies for metabolic imbalances such as hyper- and hypoglycemia. The company was established on March 4, 1993, and its primary operations are directed from its headquarters in Ahmedabad, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:18 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹3,576.90-₹104.05 (-2.83%)
Kwality Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 7.49% below the high.
₹956.60+₹10.10 (+1.07%)
Sakar Healthcare Limited’s quoted price sits in the upper half of its reported 52-week range, 22.22% below the high.
₹1,273.00-₹16.30 (-1.26%)
Venus Remedies Limited’s quoted price sits in the upper half of its reported 52-week range, 37.73% below the high.
₹244.25-₹7.75 (-3.08%)
Kopran Limited’s quoted price sits in the upper half of its reported 52-week range, 17.44% below the high.
₹511.00+₹1.10 (+0.22%)
Lincoln Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 33.64% below the high.
₹841.00-₹32.80 (-3.75%)
Remus Pharmaceuticals Ltd.’s quoted price sits in the upper half of its reported 52-week range, 19.06% below the high.
₹173.55+₹5.15 (+3.06%)
Sanjivani Paranteral Limited.’s quoted price sits in the lower half of its reported 52-week range, 28.87% below the high.
₹81.25-₹3.36 (-3.97%)
Bal Pharma Limited’s quoted price sits in the lower half of its reported 52-week range, 34.79% below the high.
